Meyka Pro banner
Haleon plc

Haleon plc (HLN) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

HLN●NYSE
HealthcareDrug Manufacturers - Specialty & Generic
$9.07
$0.11(1.14%)
U.S. Market opens in 11h 37m

Haleon plc (HLN)

Meyka AI Score

Z

Key Financials

Market Cap39.9B
P/E Ratio10.78
EPS (TTM)$0.49
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$9.53
3 Months$9.20
1 Year Target$9.69

HLN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Haleon plc (NYSE: HLN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Haleon plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HLN on the NYSE shows an RSI of 35.88, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $9.69 for the NYSE listing.

Key metrics behind Haleon plc's NYSE-traded stock include a P/E ratio of 10.78 and a market capitalization of 39.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HLN on the NYSE.

Price Performance (NYSE: HLN)

1-Day Change
-1.20%
5-Day Change
-2.32%
1-Month Change
-10.34%
3-Month Change
-2.84%
6-Month Change
-7.50%
Year-to-Date (YTD) Change
-10.34%
1-Year Change
2.55%
3-Year Change
8.82%
5-Year Change
20.87%
All-Time (Max) Change
20.87%

Contact Information

44 1932 822000
The Heights, Weybridge, SU, KT13 0NY

Company Facts

245,350 Employees
IPO DateJul 25, 2022
CountryGB
Actively Trading

Frequently Asked Questions